{"name":"ROCHE PALO","slug":"roche-palo","ticker":"","exchange":"","domain":"rochepalo.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharmaceuticals","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"1989-01-01","label":"Cytovene first approved","drug":"Cytovene","drugSlug":"ganciclovir","type":"approval","sentiment":"positive"},{"date":"1995-01-01","label":"Cellcept first approved","drug":"Cellcept","drugSlug":"mycophenolate-mofetil","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2034-09-02","label":"Cytovene patent expiry (Formulation)","drug":"Cytovene","drugSlug":"ganciclovir","type":"patent_expiry","sentiment":"negative"},{"date":"2039-08-16","label":"Cellcept patent expiry (Formulation)","drug":"Cellcept","drugSlug":"mycophenolate-mofetil","type":"patent_expiry","sentiment":"negative"},{"date":"2039-08-16","label":"Cellcept patent expiry (Formulation)","drug":"Cellcept","drugSlug":"mycophenolate-mofetil","type":"patent_expiry","sentiment":"negative"},{"date":"2039-08-16","label":"Cellcept patent expiry (Formulation)","drug":"Cellcept","drugSlug":"mycophenolate-mofetil","type":"patent_expiry","sentiment":"negative"},{"date":"2039-08-16","label":"Cellcept patent expiry (Formulation)","drug":"Cellcept","drugSlug":"mycophenolate-mofetil","type":"patent_expiry","sentiment":"negative"},{"date":"2039-08-16","label":"Cellcept patent expiry (Formulation)","drug":"Cellcept","drugSlug":"mycophenolate-mofetil","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Cellcept","genericName":"MYCOPHENOLATE MOFETIL","slug":"mycophenolate-mofetil","indication":"Prevention of Cardiac Transplant Rejection","status":"marketed"},{"name":"Cytovene","genericName":"GANCICLOVIR","slug":"ganciclovir","indication":"CMV Retinitis in AIDS Patients","status":"marketed"}]}],"pipeline":[{"name":"Cellcept","genericName":"MYCOPHENOLATE MOFETIL","slug":"mycophenolate-mofetil","phase":"marketed","mechanism":"Cellcept works by inhibiting the enzyme inosine-5'-monophosphate dehydrogenase 2, which is necessary for the production of guanosine nucleotides.","indications":["Prevention of Cardiac Transplant Rejection","Prevention of Kidney Transplant Rejection","Prevention of Liver Transplant Rejection","The suppression of graft-versus-host disease in hematopoietic stem cell transplantation"],"catalyst":""},{"name":"Cytovene","genericName":"GANCICLOVIR","slug":"ganciclovir","phase":"marketed","mechanism":"GANCICLOVIR works by inhibiting the DNA polymerase enzyme of cytomegalovirus, preventing viral replication.","indications":["CMV Retinitis in AIDS Patients","CMV Retinitis in Immunocompromised Patients","Cytomegaloviral retinitis","Herpes simplex dendritic keratitis","Myocardial Perfusion Imaging Adjunct"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[{"drugName":"Cytovene","drugSlug":"ganciclovir","patentNumber":"9486530","type":"Formulation","expiryDate":"2034-09-02","territory":"US","genericFilings":[]},{"drugName":"Cellcept","drugSlug":"mycophenolate-mofetil","patentNumber":"12194143","type":"Formulation","expiryDate":"2039-08-16","territory":"US","genericFilings":[]},{"drugName":"Cellcept","drugSlug":"mycophenolate-mofetil","patentNumber":"12097285","type":"Formulation","expiryDate":"2039-08-16","territory":"US","genericFilings":[]},{"drugName":"Cellcept","drugSlug":"mycophenolate-mofetil","patentNumber":"12226526","type":"Formulation","expiryDate":"2039-08-16","territory":"US","genericFilings":[]},{"drugName":"Cellcept","drugSlug":"mycophenolate-mofetil","patentNumber":"11931455","type":"Formulation","expiryDate":"2039-08-16","territory":"US","genericFilings":[]},{"drugName":"Cellcept","drugSlug":"mycophenolate-mofetil","patentNumber":"12097284","type":"Formulation","expiryDate":"2039-08-16","territory":"US","genericFilings":[]}],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}